Impact of Uterine Fibroids on Women's Fertility

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how uterine fibroids may affect pregnancy rates in women diagnosed with infertility. It involves a retrospective cohort analysis of women aged 20-50, comparing those with uterine fibroids to those without, to evaluate the influence of fibroids on fertility outcomes. The study aims to gather comprehensive clinical data to better understand the relationship between fibroids and infertility, which is a growing concern worldwide. By analyzing various factors contributing to infertility, the research seeks to shed light on the complexities of female reproductive health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age: 20-50 years
2. Diagnosed with uterine fibroids (by ultrasound or pathology) combined with infertile or non-infertile patients
3. Complete clinical data.

Exclusion Criteria:

1. Severe infectious disease or rheumatic immune disease active stage
2. Previous history of malignant tumors
3. Incomplete clinical data.

Where it's running

• Huazhong University of Science and Technology
  Wuhan, Hubei, China Recruiting

Study contacts

• Principal investigator: Shixuan Wang — Huazhong University of Science and Technology, Wuhan, Hubei, China, 430000
• Study coordinator: Shixuan Wang
• Email: shixuanwang@tjh.tjmu.edu.cn
• Phone: 86-27-83663078

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blocking RANKL with denosumab to protect ovarian follicles

  This trial will test whether giving denosumab, a drug that blocks RANKL, can help protect follicle development in women with infertility who are undergoing assisted reproduction.

  Recruiting Regionshospitalet Viborg, Skive · Skive, Midt Jylland · NCT07546552

• Effect of a 21-day comprehensive spa program on female infertility

  This study tests whether a 21-day spa treatment can impact hormonal profiles and reproductive outcomes in women ages 20-40 with infertility.

  Recruiting Institute of Spa and Balneology, public research institution · Františkovy Lázně, Carlsbad Region · NCT07542600

• Endometrial immune profile changes after putting your own PRP into the uterus

  This test will try whether putting a person's own platelet-rich plasma (PRP) into the uterus improves the uterine immune profile, thickness, hormone levels, and pregnancy rates for people undergoing IVF with euploid embryo transfer.

  Recruiting Nadezhda Women's Health Hospital · Sofia, Sofia · NCT07535190

• Day-4 embryo defragmentation to improve blastocyst formation and pregnancy outcomes

  This study tests whether removing cytoplasmic fragments from Day-4 morula-stage embryos helps people undergoing ICSI get more blastocysts and better pregnancy chances.

  Recruiting Momo Fertilife · Bisceglie, BT · NCT07500337

• PPOS versus GnRH antagonist IVF protocols for women with PCOS

  This trial will test whether a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol gives better IVF outcomes for women aged 18–40 with PCOS.

  Recruiting Hanoi General Hospital (Vietnam) · Hanoi, Hanoi · NCT07394530

• Relugolix (Ryeqo) with low‑dose add-back hormones for uterine fibroids and endometriosis and its effects on blood clotting

  This trial will test whether the GnRH antagonist Relugolix combined with low‑dose estradiol and progestin (Ryeqo) changes blood clotting markers in adult women treated for uterine fibroids or endometriosis.

  Recruiting University Hospital, Geneva · Geneva, Canton of Geneva · NCT07173127

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.